Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature

Muñoz N, 2003, N Engl J Med, 348, 518, 10.1056/NEJMoa021641

Muñoz N, 2006, Vaccine, 24, S3, 10.1016/j.vaccine.2005.10.042

Koutsky L, 1997, Am J Med, 102, 3, 10.1016/S0002-9343(97)00177-0

Winer RL, 2003, Am J Epidemiol, 157, 218, 10.1093/aje/kwf180

Schiffman M, 2003, Arch Pathol Lab Med, 127, 930, 10.5858/2003-127-930-HPEAPH

10.1093/jnci/84.6.394

Moscicki AB, 2006, Vaccine, 24, 42, 10.1016/j.vaccine.2006.06.018

Hildesheim A, 1994, J Infect Dis, 169, 235, 10.1093/infdis/169.2.235

Franco EL, 1999, J Infect Dis, 180, 1415, 10.1086/315086

Syrjänen K, Syrjänen S. Papillomavirus infections in human pathology. Chichester (UK): John Wiley & Sons2000. pp 1–615.

Cho NH, 2002, Yonsei Med J, 43, 722, 10.3349/ymj.2002.43.6.722

Clarke B, 2001, Gynecol Oncol, 82, 238, 10.1006/gyno.2001.6306

Lundberg AS, 1999, Eur J Cancer, 35, 531, 10.1016/S0959-8049(99)00292-0

Gadducci A, 2009, Crit Rev Oncol Hematol, 69, 12, 10.1016/j.critrevonc.2008.05.001

Adams PD, 2001, Biochim Biophys Acta, 1471, M123

Frolov MV, 2004, J Cell Sci, 117, 2173, 10.1242/jcs.01227

Schulze A, 1998, J Virol, 72, 2323, 10.1128/JVI.72.3.2323-2334.1998

Southern SA, 1998, Cancer Res, 58, 2941

Hengst L, 1998, Curr Top Microbiol Immunol, 227, 25

Sherr CJ, 2001, Nat Rev Mol Cell Biol, 2, 731, 10.1038/35096061

10.1016/S0163-7258(01)00159-0

Funk JO, 1997, Genes Dev, 11, 2090, 10.1101/gad.11.16.2090

Santopietro R, 2006, Cancer Epidemiol Biomarkers Prev, 15, 1250, 10.1158/1055-9965.EPI-06-0086

Deacon JM, 2000, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523

Moreno V, 2002, Lancet, 359, 1085, 10.1016/S0140-6736(02)08150-3

Bosch FX, 2007, Dis Markers, 23, 213, 10.1155/2007/914823

Klumb EM, 2010, J Clin Rheumatol, 16, 153, 10.1097/RHU.0b013e3181df5261

Einstein MH, 2010, Curr Opin Oncol, 22, 449, 10.1097/CCO.0b013e32833cff4f

Finan RR, 2006, Clin Microbiol Infect, 12, 927, 10.1111/j.1469-0691.2006.01479.x

Kwaśniewska A, 2009, Eur J Gynaecol Oncol, 30, 65

Brinton LA, 1986, JAMA, 255, 3265, 10.1001/jama.1986.03370230071033

Kjaer SK, 1996, Eur J Cancer Prev, 5, 359, 10.1097/00008469-199610000-00008

Kjellberg L, 2000, Br J Cancer, 82, 1332, 10.1054/bjoc.1999.1100

Plummer M, 2003, Cancer Causes Control, 14, 805, 10.1023/B:CACO.0000003811.98261.3e

Castellsague X, 2003, J Natl Cancer Inst Monogr, 31, 20, 10.1093/oxfordjournals.jncimonographs.a003477

10.1111/j.1349-7006.2010.01642.x

Prokopczyk B, 1997, J Natl Cancer Inst, 89, 868, 10.1093/jnci/89.12.868

Melikian AA, 1999, Cancer Lett, 146, 127, 10.1016/S0304-3835(99)00203-7

Poppe WA, 1995, Gynecol Obstet Invest, 39, 34, 10.1159/000292372

Stampfli MR, 2009, Nat Rev Immunol, 9, 377, 10.1038/nri2530

Alam S, 2008, J Virol, 82, 1053, 10.1128/JVI.01813-07

Sundberg K, 1998, Carcinogenesis, 19, 433, 10.1093/carcin/19.3.433

Jee SH, 2002, Yonsei Med J, 43, 712, 10.3349/ymj.2002.43.6.712

Meeuwis KA, 2010, Transpl Int, 23, 191, 10.1111/j.1432-2277.2009.00975.x

Bernatsky S, 2009, Best Pract Res Clin Rheumatol, 23, 539, 10.1016/j.berh.2008.12.007

Singh H, 2009, Gastroenterology, 136, 451, 10.1053/j.gastro.2008.10.021

Lees CW, 2009, Inflamm Bowel Dis, 15, 1621, 10.1002/ibd.20959

Heard I, 2000, Obstet Gynecol, 96, 403, 10.1016/S0029-7844(00)00948-0

Ellerbrock TV, 2000, JAMA, 283, 1031, 10.1001/jama.283.8.1031

Ahdieh L, 2001, J Infect Dis, 184, 682, 10.1086/323081

10.1093/jnci/95.14.1062

Mogtomo ML, 2009, Infect Agent Cancer, 3, 4

Hawes SE, 2003, J Infect Dis, 188, 555, 10.1086/376996

Moukassa D, 2007, Med Trop, 67, 57

Yamada R, 2008, J Med Virol, 80, 847, 10.1002/jmv.21170

de Jong A, 2004, Cancer Res, 64, 5449, 10.1158/0008-5472.CAN-04-0831

10.1086/322856

10.1093/jnci/djh192

Klein J, 2000, First of two parts. N Engl J Med, 343, 702, 10.1056/NEJM200009073431006

Stephens HA, 2005, Trends Immunol, 26, 41, 10.1016/j.it.2004.11.001

Chan DP, 2005, J Infect Dis, 192, 1749, 10.1086/497342

Madeleine MM, 2008, Cancer Res, 68, 3532, 10.1158/0008-5472.CAN-07-6471

Hosono S, 2010, J Epidemiol, 20, 295, 10.2188/jea.JE20090155

Deligeoroglou E, 2003, Ann N Y Acad Sci, 997, 199, 10.1196/annals.1290.023

10.1016/j.ajog.2004.01.061

Vessey M, 2006, Br J Cancer, 95, 385, 10.1038/sj.bjc.6603260

Shapiro S, 2003, Cancer Causes Control, 14, 485, 10.1023/A:1024910808307

Green J, 2003, Br J Cancer, 89, 2078, 10.1038/sj.bjc.6601296

Smith JS, 2003, Lancet, 361, 1159, 10.1016/S0140-6736(03)12949-2

Berrington de Gonzalez A, 2004, Br J Cancer, 90, 1787, 10.1038/sj.bjc.6601764

Moodley J, 2004, Curr Opin Obstet Gynecol, 16, 27, 10.1097/00001703-200402000-00006

International Collaboration of Epidemiological Studies of Cervical Cancer, 2007, Lancet, 370, 1609, 10.1016/S0140-6736(07)61684-5

Li C, 2010, Cancer Epidemiol Biomarkers Prev, 19, 2655, 10.1158/1055-9965.EPI-10-0212

Mitrani-Rosenbaum S, 1989, J Gen Virol, 70, 2227, 10.1099/0022-1317-70-8-2227

Cibula D, 2010, Hum Reprod Update, 16, 631, 10.1093/humupd/dmq022

Vessey M, 2010, Contraception, 82, 221, 10.1016/j.contraception.2010.04.006

Schmeink CE, 2010, Obstet Gynecol, 116, 67, 10.1097/AOG.0b013e3181e238f0

Gavric-Lovrec V, 2010, Int J STD AIDS, 21, 424, 10.1258/ijsa.2010.009580

Marks M, Int J Cancer

10.1002/ijc.10868

Moodley M, 2003, Int J Gynecol Cancer, 13, 103, 10.1046/j.1525-1438.2003.13030.x

Hellberg D, 2005, Anticancer Res, 25, 3041

Nees M, 2000, Cancer Res, 60, 4289

10.1016/S0149-7634(00)00027-0

Loy RA, 1992, Fertil Steril, 58, 733, 10.1016/S0015-0282(16)55320-5

Konecna L, 2000, Brain Behav Immun, 14, 49, 10.1006/brbi.1999.0570

Polan ML, 1989, J Clin Endocrinol Metab, 69, 1200, 10.1210/jcem-69-6-1200

Agarwal SK, 1999, Ann Allergy Asthma Immunol, 83, 222, 10.1016/S1081-1206(10)62644-0

Kanda N, 1999, J Allergy Clin Immunol, 103, 282, 10.1016/S0091-6749(99)70503-8

Rogers A, 2001, Bone, 29, 30, 10.1016/S8756-3282(01)00468-9

Prieto G A, 2006, Immunology, 118, 58, 10.1111/j.1365-2567.2006.02339.x

Beagley KW, 2003, FEMS Immunol Med Microbiol, 38, 13, 10.1016/S0928-8244(03)00202-5

Mjosberg J, 2009, J Immunol, 183, 759, 10.4049/jimmunol.0803654

10.1002/ijc.2910440515

Persson I, 1996, Int J Cancer, 67, 327, 10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T

Parazzini F, 1997, BMJ, 315, 85, 10.1136/bmj.315.7100.85

Schneider C, 2009, Climacteric, 1, 1, 10.1080/13697130903075352

10.1016/0090-8258(87)90270-8

10.1016/j.maturitas.2003.09.031

Hinds L, 2010, Menopause Int, 16, 89, 10.1258/mi.2010.010018

10.1016/j.maturitas.2009.11.017

Harper DM, 2004, Lancet, 364, 1757, 10.1016/S0140-6736(04)17398-4

Villa LL, 2005, Lancet Oncol, 6, 271, 10.1016/S1470-2045(05)70101-7

Adams M, 2007, Vaccine, 25, 3007, 10.1016/j.vaccine.2007.01.016

Armstrong EP, 2010, J Manag Care Pharm, 16, 217, 10.18553/jmcp.2010.16.3.217

Marks M, 2010, Clin Vaccine Immunol, 17, 609, 10.1128/CVI.00441-09

Buckner JH, 2008, Ann N Y Acad Sci, 1143, 151, 10.1196/annals.1443.014

Arbyn M, 2006, Vaccine, 24, 78, 10.1016/j.vaccine.2006.05.117

Mayrand MH, 2007, N Engl J Med, 357, 1579, 10.1056/NEJMoa071430

Cuzick J, 2006, Int J Cancer, 119, 1095, 10.1002/ijc.21955

Ronco G, 2010, Lancet Oncol, 11, 249, 10.1016/S1470-2045(09)70360-2

von Knebel Doeberitz M, 2002, Eur J Cancer, 38, 2229, 10.1016/S0959-8049(02)00462-8

Carozzi F, 2008, Lancet Oncol, 9, 937, 10.1016/S1470-2045(08)70208-0

Coquillard G, 2010, Gynecol Oncol, 120, 89, 10.1016/j.ygyno.2010.09.013

Nakao Y, 1997, Br J Cancer, 75, 1410, 10.1038/bjc.1997.243

Naucler P, 2009, J Natl Cancer Inst, 101, 88, 10.1093/jnci/djn444